|
1
|
Jemal A, Bray F, Center MM, Ferlay JJ,
Ward E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu
Y, Chen Y, Xu L, Zen K, Zhang C and Shen H: Serum microRNA
signatures identified in a genome-wide serum microRNA expression
profiling predict survival of non-small-cell lung cancer. J Clin
Oncol. 28:1721–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peters S, Adjei AA, Gridelli C, Reck M,
Kerr K and Felip E: ESMO Guidelines Working Group: Metastatic
non-small-cell lung cancer: ESMO clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 23 Suppl
7:vii56–vii64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giovannetti E, Toffalorio F, De Pas T and
Peters GJ: Pharmacogenetics of conventional chemotherapy in
non-small-cell lung cancer: A changing landscape? Pharmacogenomics.
13:1073–1086. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Osada H and Takahashi T: MicroRNAs in
biological processes and carcinogenesis. Carcinogenesis. 28:2–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:pp. 15805–15810. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang HW, Wang EW, Li LX, Yi SH, Li LC, Xu
FL, Wang DL, Wu YZ and Nian WQ: A regulatory loop involving miR-29c
and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal
transition in lung cancer. Oncotarget. 7:85905–85916.
2016.PubMed/NCBI
|
|
9
|
Gu A, Lu J, Wang W, Shi C, Han B and Yao
M: Role of miR-497 in VEGF-A-mediated cancer cell growth and
invasion in non-small cell lung cancer. Int J Biochem Cell Biol.
70:118–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Claesson-Welsh L and Welsh M: VEGFA and
tumour angiogenesis. J Intern Med. 273:114–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Liu X, Zhang J, Li L and Liu C:
The expression and clinical significance of PI3K, pAkt and VEGF in
colon cancer. Oncol Lett. 4:763–766. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chuang JC, Neal JW, Niu XM and Wakelee HA:
Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current
data and future prospects. Lung Cancer. 90:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
NSCLC Meta-analyses Collaborative Group1,
. Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le
Chevalier T, Le Pechoux C, Parmar MK, Pignon JP, et al: Adjuvant
chemotherapy, with or without postoperative radiotherapy, in
operable non-small-cell lung cancer: Two meta-analyses of
individual patient data. Lancet. 375:1267–1277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomas A, Liu SV, Subramaniam DS and
Giaccone G: Refining the treatment of NSCLC according to
histological and molecular subtypes. Nat Rev Clin Oncol.
12:511–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tibaldi C, D'Incecco A and Lagana A:
MicroRNAs and targeted therapies in non-small cell lung cancer:
Minireview. Anticancer Agents Med Chem. 15:694–700. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 105:pp.
13027–13032. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y,
Wang X, Zou B, Zhang S, Jing T, et al: miR-29a/b enhances cell
migration and invasion in nasopharyngeal carcinoma progression by
regulating SPARC and COL3A1 gene expression. PLoS One.
10:e01209692015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lei X, Lei L, Zhang Z, Zhang Z and Cheng
Y: Downregulated miR-29c correlates with increased BACE1 expression
in sporadic Alzheimer's disease. Int J Clin Exp Pathol.
8:1565–1574. 2015.PubMed/NCBI
|
|
20
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93, and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang
L, Zhang H, Chen X, Yang Y and Liu G: miRNA-29c suppresses lung
cancer cell adhesion to extracellular matrix and metastasis by
targeting integrin β1 and matrix metalloproteinase2 (MMP2). PLoS
One. 8:e701922013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goos JA, de Cuba EM, Coupé VM, Diosdado B,
Delis-Van Diemen PM, Karga C, Beliën JA, Menke-Van der Houven van
Oordt CW, Geldof AA, Meijer GA, et al: Glucose transporter 1
(SLC2A1) and vascular endothelial growth factor a (VEGFA) predict
survival after resection of colorectal cancer liver metastasis. Ann
Surg. 263:138–145. 2016.PubMed/NCBI
|
|
23
|
Mao D, Zhang Y, Lu H and Zhang H:
Molecular basis underlying inhibition of metastasis of gastric
cancer by anti-VEGFa treatment. Tumor Biol. 35:8217–8223. 2014.
View Article : Google Scholar
|
|
24
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL and Wang J: TGF-beta suppresses VEGFA-mediated angiogenesis in
colon cancer metastasis. PLoS One. 8:e599182013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
